THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS

Abdalla, 1985, Prevention of bone mineral loss in postmenopausal women by northesterone, Obstet Gynecol, 66, 789 Albright, 1941, Postmenopausal osteoporosis, JAMA, 116, 2465, 10.1001/jama.1941.02820220007002 Blunt, 1994, Sex differences in BMD in 1653 men and women in the sixth through the tenth decades of life: The Rancho Bernardo Study, J Bone Miner Res, 9, 1333, 10.1002/jbmr.5650090903 Cauley, 1995, Estrogen replacement therapy and fractures in older women, Ann Intern Med, 122, 9, 10.7326/0003-4819-122-1-199501010-00002 Christiansen, 1990, Five years with continuous combined oestrogen progesterone therapy: Effects on calcium metabolism, lipoprotein, and bleeding pattern, Br J Obstet Gynaecol, 97, 1087, 10.1111/j.1471-0528.1990.tb02495.x Christiansen, 1990, 17-estradiol and continuous norethistrone: A unique treatment for established osteoporosis in elderly women, J Clin Endocrinol Metab, 71, 836, 10.1210/jcem-71-4-836 Christiansen, 1987, Prediction of rapid bone loss in premenopausal women, Lancet, 1, 1105, 10.1016/S0140-6736(87)91671-0 Christiansen, 1981, Bone mass in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy, Lancet, 1, 459, 10.1016/S0140-6736(81)91848-1 Editor, 1950, Queries and minor notes, JAMA, 144, 358, 10.1001/jama.1950.02920040072054 Eriksen, 1988, Evidence of estrogen receptors in normal human osteoblast like cells, Science, 241, 84, 10.1126/science.3388021 Eriksen, 1990, Cancellous bone remodeling in type I postmenopausal osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels, J Bone Miner Res, 5, 311, 10.1002/jbmr.5650050402 Felson, 1993, The effect of postmenopausal estrogen therapy on bone density in elderly women, N Engl J Med, 329, 1149, 10.1056/NEJM199310143291601 Field, 1993, Preventive effects of transdermal 17-beta-estradiol on osteoporotic changes after surgical menopause: A two year placebo controlled trial, Am J Obstet Gynecol, 168, 114, 10.1016/S0002-9378(12)90897-2 Gallagher, 1991, Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen, Am J Med, 90, 171, 10.1016/0002-9343(91)80156-G Gallagher, 1990, Effect of estrone sulfate on bone mineral density of the femoral neck and spine, J Bone Miner Res, 5, S275 Genant, 1982, Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy, Ann Intern Med, 97, 699, 10.7326/0003-4819-97-5-699 Girasole G, Jilka RL, Passeri G: 17-beta-estradiol inhibits interleukin-6 production by bone marrow derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiresorptive effect of estrogens. J Clin Invest 89:883–891 Grady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326/0003-4819-117-12-1016 Greenspan, 1994, Femoral bone loss progresses with age: A longitudinal study in women over age 65, J Bone Miner Res, 9, 1959, 10.1002/jbmr.5650091216 Guyatt, 1996, An introduction to clinical decision making in osteoporosis, 145 Guyatt, 1995, A method for grading health care recommendations, JAMA, 274, 1800, 10.1001/jama.1995.03530220066035 Hammond, 1996, Menopause and hormone replacement therapy: An overview, Obstet Gynecol, 87, 2S, 10.1016/0029-7844(95)00429-7 Harris, 1992, Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women, Calcif Tissue Int, 5, 19, 10.1007/BF00297292 Harris, 1992, Rates of change in BMD of the spine, heel, femoral neck and radius in healthy postmenopausal women, Bone Miner, 17, 87, 10.1016/0169-6009(92)90713-N Hauschka, 1986, Growth factors in bone matrix, J Biol Chem, 261, 12665, 10.1016/S0021-9258(18)67143-1 Heaney, 1996, Nutrition and risk for osteoporosis, 483 Horsman, 1977, Prospective trial of estrogen and calcium in postmenopausal women, BMJ, 2, 789, 10.1136/bmj.2.6090.789 Jilka, 1992, Increased osteoclast development after estrogen loss: Mediation by IL-6, Science, 257, 88, 10.1126/science.1621100 Khosla, 1994, Circulating cytokine levels in osteoporotic and normal women, J Clin Endocrinol Metab, 79, 707, 10.1210/jc.79.3.707 Kitazawa, 1994, IL-1 receptor antagonist and TNF binding protein decrease osteoclast formation and bone resorption in ovariectomized mice, J Clin Invest, 94, 2397, 10.1172/JCI117606 Lieberman, 1995, Effect of alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis, N Engl J Med, 332, 1437, 10.1056/NEJM199511303332201 Lindsay, 1980, Prevention of spinal osteoporosis in oophorectomized women, Lancet, 2, 1151, 10.1016/S0140-6736(80)92592-1 Lindsay, 1978, Bone response to termination of estrogen treatment, Lancet, 1, 1325, 10.1016/S0140-6736(78)92402-9 Lindsay, 1990, Estrogen treatment of patients with established postmenopausal osteoporosis, Obstet Gynecol, 72, 290 Lufkin, 1992, Treatment of postmenopausal osteoporosis with transdermal estrogen, Ann Intern Med, 117, 1, 10.7326/0003-4819-117-1-1 Manolagas, 1995, Emerging insights into the pathophysiology of osteoporosis, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506 Manolagas, 1992, Cytokines hematopoiesis, osteoclastogenesis, and estrogens, Calcif Tissue Int, 50, 199, 10.1007/BF00296282 Marcus, 1995, Effects of hormone replacement therapies on BMD: Results from the Postmenopausal Estrogen and Progestin Interventions Trial, J Bone Miner Res, 10, 276 Marcus, 1994, Organization and functional aspects of skeletal health, 12 Marx, 1992, Do estrogens improve bone mineral density in osteoporotic women over age 65, J Bone Miner Res, 7, 1275, 10.1002/jbmr.5650071122 Maxim, 1995, Fracture protection provided by long-term estrogen treatment, Osteoporosis Int, 5, 23, 10.1007/BF01623654 Moore, 1990, Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density, J Bone Miner Res, 5, 659, 10.1002/jbmr.5650050616 Mundy, 1987, Bone resorption and turnover in health and disease, Bone, 8, S9 Nachtigall, 1979, Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis, Obstet Gynecol, 53, 277 Naessen, 1990, Hormone replacement therapy and the risk for a first hip fracture: A prospective population-based cohort study, Ann Intern Med, 113, 95, 10.7326/0003-4819-113-2-95 Nordin, 1980, Treatment of spinal osteoporosis in postmenopausal women, BMJ, 280, 451, 10.1136/bmj.280.6212.451 Pacifici, 1991, Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells, Proc Natl Acad Sci USA, 88, 5134, 10.1073/pnas.88.12.5134 Pacifici, 1993, Monocytic secretion of IL-1 receptor antagonist in normal and osteoporotic women: Effect of menopause and estrogen/progesterone therapy, J Clin Endocrinol Metab, 77, 1135, 10.1210/jc.77.5.1135 Paganini-Hill, 1991, Exercise and other factors in the prevention of hip fracture: The Leisure World Study, Epidemiology, 2, 16, 10.1097/00001648-199101000-00004 Parfitt AM: Osteonal and heim-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55:273–286 Parfitt, 1983, Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: Implications for the microanatomic and cellular mechanism of bone loss, J Clin Invest, 72, 1396, 10.1172/JCI111096 Passeri, 1993, Increased IL-6 production by murine bone marrow and bone cells following estrogen withdrawal, Endocrinology, 133, 822, 10.1210/en.133.2.822 Pors, 1994, Magnitude and pattern of skeletal response to long term continuous and cyclic sequential estrogen/progestin treatment, Br J Obstet Gynaecol, 101, 319, 10.1111/j.1471-0528.1994.tb13618.x Quigley, 1987, Estrogen therapy arrests bone loss in elderly women, Am J Obstet Gynecol, 156, 1516, 10.1016/0002-9378(87)90025-1 Raisz, 1988, Local and systemic factors in the pathogenesis of osteoporosis, N Engl J Med, 318, 818, 10.1056/NEJM198803313181305 Ravn, 1994, Premenopausal and postmenopausal changes in BMD of the proximal femur measured by DEXA, J Bone Miner Res, 9, 1975, 10.1002/jbmr.5650091218 Recker, 1977, Effects of estrogens and calcium carbonate on bone loss in postmenopausal women, Ann Intern Med, 87, 649, 10.7326/0003-4819-87-6-649 Resch, 1990, Effects of one year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures, Acta Endocrinol, 123, 14, 10.1530/acta.0.1230014 Riggs, 1982, Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: Comparison with conventional therapy, N Engl J Med, 322, 802, 10.1056/NEJM199003223221203 Rodan, 1996, Coupling of bone resorption and formation during bone remodeling, 289 Rosen, 1996, A comparison of biochemical markers in monitoring skeletal response to HRT in early postmenopausal women, J Bone Miner Res, 11, S1 Suda, 1992, Modulation of osteoclast differentiation, Endocr Rev, 13, 66, 10.1210/edrv-13-1-66 Tanaka, 1993, Macrophage colony stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors, J Clin Invest, 91, 257, 10.1172/JCI116179 Tremollieres, 1993, Effect of long-term administration of progestogen on postmenopausal bone loss: Results of a two year controlled randomized study, Clin Endocrinol Metab, 38, 627 Wasnich, 1983, Postmenopausal bone loss at multiple skeletal sites: Relationship to estrogen use, J Chron Dis, 36, 781, 10.1016/0021-9681(83)90070-X Weiss, 1980, Decreased risk of fracture of the hip and lower forearm with the postmenopausal use of estrogen, N Engl J Med, 303, 1195, 10.1056/NEJM198011203032102 The Writing Group for the PEPI Trial, 1995, Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women, JAMA, 273, 199, 10.1001/jama.1995.03520270033028 Yeh J, Kohlmeier L, LeBoff MS, et al: Expression of aromatase P450 in marrow from men and postmenopausal women. Presented at the Endocrine Society 77th Annual Meeting, Washington, DC, 1995, p 88 Zarrabeitia, 1991, Cytokine production by blood cells in postmenopausal osteoporosis, Bone Miner, 14, 161, 10.1016/0169-6009(91)90093-F